Study on Long-term Effects of COVID-19 Infection

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

Recruiting Observational Study
COVID
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
University of California, San Francisco · Other
Who this trial is looking for

This trial is looking for volunteers who have recovered from COVID-19. Participants will provide samples to help researchers learn about the immune response after infection.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old.
  • I have a history of COVID-19 infection.
  • I can provide written consent.
  • I had my first positive COVID-19 test or symptoms at least 21 days ago.

You may not be able to join if

  • I have chronic anemia with hemoglobin less than 9 g/dL.
  • I have a serious medical or psychiatric illness that affects my ability to participate.
  • I actively use drugs or alcohol in a way that affects my ability to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-1…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Willing and able to provide written informed consent, and 2. Age \>/= 18 years, and 3. A history of SARS-CoV-2 infection, as evidenced by: 1. Available laboratory documentation of SARS-CoV-2 RNA positivity on a nucleic acid amplification test or by serologic testing when …
Contacts

Emily A Fehrman, MPH

(650) 761-2163

emily.fehrman2@ucsf.edu

CONTACT

Michael J Peluso, MD

415-476-9363

michael.peluso@ucsf.edu

CONTACT